Cargando…

287 Nasal Nitric Oxide Levels after Lysine Aspirin Nasal Challenge in Subjects with Aspirin Induced Asthma

BACKGROUND: Changes in nasal nitric oxide (nNO) levels after nasal lysine aspirin (lys-ASA) challenge have not been determined. METHODS: Fourteen patients with aspirin induced asthma (AIA) with or without nasal polyps with aspirin were included to the study. Hypersensitivity had to be confirmed by p...

Descripción completa

Detalles Bibliográficos
Autores principales: Tworek, Damian, Bochenska-Marciniak, Malgorzata, Kuprys-Lipinska, Izabela, Pietruszewska, Wioletta, Zielinska-Wyderkiewicz, Ewa, Kuna, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512596/
http://dx.doi.org/10.1097/01.WOX.0000412044.51952.b9
_version_ 1782251756922601472
author Tworek, Damian
Bochenska-Marciniak, Malgorzata
Kuprys-Lipinska, Izabela
Pietruszewska, Wioletta
Zielinska-Wyderkiewicz, Ewa
Kuna, Piotr
author_facet Tworek, Damian
Bochenska-Marciniak, Malgorzata
Kuprys-Lipinska, Izabela
Pietruszewska, Wioletta
Zielinska-Wyderkiewicz, Ewa
Kuna, Piotr
author_sort Tworek, Damian
collection PubMed
description BACKGROUND: Changes in nasal nitric oxide (nNO) levels after nasal lysine aspirin (lys-ASA) challenge have not been determined. METHODS: Fourteen patients with aspirin induced asthma (AIA) with or without nasal polyps with aspirin were included to the study. Hypersensitivity had to be confirmed by positive result of oral aspirin challenge Ten healthy subjects served as the control group. 12 mg of lys-ASA were applied unilaterally. Nasal symptoms were assessed using visual analogue scale (VAS) and nNO and peak nasal inspiratory flow (PNIF) measurements were performed before and 1, 2, 4 and 24 hours after the challenge. The result of the challenge was considered as positive when at least 20% fall of PNIF as well as 20% increase of total VAS score were observed. RESULTS: Ten patients (71.4%) had clinically positive result of the challenge. We observed significant fall in nNO levels in AIA patients after 1 and 2 hours after the challenge (653. 1 ± 420. 2 at baseline versus 490. 3 ± 456. 0; P = 0.0029 and 439. 9 ± 556. 4 ppb; P = 0.0076; respectively). The decrease in nNO level was more pronounced in patients with clinically positive result of the challenge (510. 1 ± 212. 5 at baseline versus 283. 3 ± 173. 4; P = 0.005; 159, 6 ± 166,1; P = 0.005 and 331. 0 ± 312.0 ppb; P = 0.037 after 1, 2 and 3 hours, respectively). In 4 subjects with clinically negative result of the challenge we noticed a trend towards higher nNO concentrations after lys-ASA challenge (1010. 8 ± 625. 2 at baseline vs 1341. 3 ± 670. 5 ppb after 4 hours). No significant changes in nNO levels after the challenge were observed in healthy controls. CONCLUSIONS: NO levels decrease after lys-ASA nasal challenge in subjects with AIA and clinically positive nasal provocation. An unexpected trend towards increase in nNO levels was observed in subjects with AIA and clinically negative provocation Potential usefulness of nNO measurement in aspirin nasal provocation needs further evaluation.
format Online
Article
Text
id pubmed-3512596
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher World Allergy Organization Journal
record_format MEDLINE/PubMed
spelling pubmed-35125962012-12-21 287 Nasal Nitric Oxide Levels after Lysine Aspirin Nasal Challenge in Subjects with Aspirin Induced Asthma Tworek, Damian Bochenska-Marciniak, Malgorzata Kuprys-Lipinska, Izabela Pietruszewska, Wioletta Zielinska-Wyderkiewicz, Ewa Kuna, Piotr World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: Changes in nasal nitric oxide (nNO) levels after nasal lysine aspirin (lys-ASA) challenge have not been determined. METHODS: Fourteen patients with aspirin induced asthma (AIA) with or without nasal polyps with aspirin were included to the study. Hypersensitivity had to be confirmed by positive result of oral aspirin challenge Ten healthy subjects served as the control group. 12 mg of lys-ASA were applied unilaterally. Nasal symptoms were assessed using visual analogue scale (VAS) and nNO and peak nasal inspiratory flow (PNIF) measurements were performed before and 1, 2, 4 and 24 hours after the challenge. The result of the challenge was considered as positive when at least 20% fall of PNIF as well as 20% increase of total VAS score were observed. RESULTS: Ten patients (71.4%) had clinically positive result of the challenge. We observed significant fall in nNO levels in AIA patients after 1 and 2 hours after the challenge (653. 1 ± 420. 2 at baseline versus 490. 3 ± 456. 0; P = 0.0029 and 439. 9 ± 556. 4 ppb; P = 0.0076; respectively). The decrease in nNO level was more pronounced in patients with clinically positive result of the challenge (510. 1 ± 212. 5 at baseline versus 283. 3 ± 173. 4; P = 0.005; 159, 6 ± 166,1; P = 0.005 and 331. 0 ± 312.0 ppb; P = 0.037 after 1, 2 and 3 hours, respectively). In 4 subjects with clinically negative result of the challenge we noticed a trend towards higher nNO concentrations after lys-ASA challenge (1010. 8 ± 625. 2 at baseline vs 1341. 3 ± 670. 5 ppb after 4 hours). No significant changes in nNO levels after the challenge were observed in healthy controls. CONCLUSIONS: NO levels decrease after lys-ASA nasal challenge in subjects with AIA and clinically positive nasal provocation. An unexpected trend towards increase in nNO levels was observed in subjects with AIA and clinically negative provocation Potential usefulness of nNO measurement in aspirin nasal provocation needs further evaluation. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3512596/ http://dx.doi.org/10.1097/01.WOX.0000412044.51952.b9 Text en Copyright © 2012 by World Allergy Organization
spellingShingle Abstracts of the XXII World Allergy Congress
Tworek, Damian
Bochenska-Marciniak, Malgorzata
Kuprys-Lipinska, Izabela
Pietruszewska, Wioletta
Zielinska-Wyderkiewicz, Ewa
Kuna, Piotr
287 Nasal Nitric Oxide Levels after Lysine Aspirin Nasal Challenge in Subjects with Aspirin Induced Asthma
title 287 Nasal Nitric Oxide Levels after Lysine Aspirin Nasal Challenge in Subjects with Aspirin Induced Asthma
title_full 287 Nasal Nitric Oxide Levels after Lysine Aspirin Nasal Challenge in Subjects with Aspirin Induced Asthma
title_fullStr 287 Nasal Nitric Oxide Levels after Lysine Aspirin Nasal Challenge in Subjects with Aspirin Induced Asthma
title_full_unstemmed 287 Nasal Nitric Oxide Levels after Lysine Aspirin Nasal Challenge in Subjects with Aspirin Induced Asthma
title_short 287 Nasal Nitric Oxide Levels after Lysine Aspirin Nasal Challenge in Subjects with Aspirin Induced Asthma
title_sort 287 nasal nitric oxide levels after lysine aspirin nasal challenge in subjects with aspirin induced asthma
topic Abstracts of the XXII World Allergy Congress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512596/
http://dx.doi.org/10.1097/01.WOX.0000412044.51952.b9
work_keys_str_mv AT tworekdamian 287nasalnitricoxidelevelsafterlysineaspirinnasalchallengeinsubjectswithaspirininducedasthma
AT bochenskamarciniakmalgorzata 287nasalnitricoxidelevelsafterlysineaspirinnasalchallengeinsubjectswithaspirininducedasthma
AT kupryslipinskaizabela 287nasalnitricoxidelevelsafterlysineaspirinnasalchallengeinsubjectswithaspirininducedasthma
AT pietruszewskawioletta 287nasalnitricoxidelevelsafterlysineaspirinnasalchallengeinsubjectswithaspirininducedasthma
AT zielinskawyderkiewiczewa 287nasalnitricoxidelevelsafterlysineaspirinnasalchallengeinsubjectswithaspirininducedasthma
AT kunapiotr 287nasalnitricoxidelevelsafterlysineaspirinnasalchallengeinsubjectswithaspirininducedasthma